Italian PACS firm Program gets nod for MedStationProgram S.r.l. of Vicenza, Italy, has received 510(k) clearance from the Food and Drug Administration for its MedStation line of Windows NT-based PACS products (PNN 9/97). Program plans to
Program S.r.l. of Vicenza, Italy, has received 510(k) clearance from the Food and Drug Administration for its MedStation line of Windows NT-based PACS products (
PNN
9/97). Program plans to sell MedStation in the U.S. through dealers and distributors, and is pursuing agreements with interested parties, according to a company spokesperson. Program is negotiating with Swissray International for rights to the product line on a nonexclusive basis.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Study Shows Enhanced Diagnosis of Coronary Artery Stenosis with Photon-Counting CTA
July 10th 2025In a new study comparing standard resolution and ultra-high resolution modes for patients undergoing coronary CTA with photon-counting detector CT, researchers found that segment-level sensitivity and accuracy rates for diagnosing coronary artery stenosis were consistently > 89.6 percent.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.